Significance
Most studies of neurotransmitter:sodium symporter (NSS) function and dynamics have been carried out in detergent even though the activity of these integral membrane proteins is heavily modulated by surrounding lipids. Here, we reconstituted the prokaryotic homolog LeuT into nanodiscs and subjected the preparation to hydrogen–deuterium exchange mass spectrometry to reveal a global view of the hallmarks of the transporter in two disparate conformations. The data were interpreted with the aid of molecular dynamics simulations, allowing unprecedented atomic-level insights into the dynamics of an unmodified, unlabeled NSS in a native-like lipid bilayer environment.
Keywords: nanodisc, hydrogen–deuterium exchange mass spectrometry, conformational dynamics, neurotransmitter symporter, molecular dynamics simulations
Abstract
Neurotransmitter:sodium symporters (NSSs) are integral membrane proteins responsible for the sodium-dependent reuptake of small-molecule neurotransmitters from the synaptic cleft. The symporters for the biogenic amines serotonin (SERT), dopamine (DAT), and norepinephrine (NET) are targets of multiple psychoactive agents, and their dysfunction has been implicated in numerous neuropsychiatric ailments. LeuT, a thermostable eubacterial NSS homolog, has been exploited as a model protein for NSS members to canvass the conformational mechanism of transport with a combination of X-ray crystallography, cysteine accessibility, and solution spectroscopy. Despite yielding remarkable insights, these studies have primarily been conducted with protein in the detergent-solubilized state rather than embedded in a membrane mimic. In addition, solution spectroscopy has required site-specific labeling of nonnative cysteines, a labor-intensive process occasionally resulting in diminished transport and/or binding activity. Here, we overcome these limitations by reconstituting unlabeled LeuT in phospholipid bilayer nanodiscs, subjecting them to hydrogen–deuterium exchange coupled with mass spectrometry (HDX-MS), and facilitating interpretation of the data with molecular dynamics simulations. The data point to changes of accessibility and dynamics of structural elements previously implicated in the transport mechanism, in particular transmembrane helices (TMs) 1a and 7 as well as extracellular loops (ELs) 2 and 4. The results therefore illuminate the value of this strategy for interrogating the conformational mechanism of the more clinically significant mammalian membrane proteins including SERT and DAT, neither of which tolerates complete removal of endogenous cysteines, and whose activity is heavily influenced by neighboring lipids.
Neurotransmitter:sodium symporters (NSSs) are secondary active transporters that harness preexisting sodium gradients to translocate small-molecule neurotransmitters from the synapse to the presynaptic neuron and surrounding glial cells subsequent to postsynaptic receptor activation. They include the clinically relevant transporters for serotonin (SERT), dopamine (DAT), norepinephrine, γ-aminobutyric acid, and glycine, and are targets of a wide array of psychotropic compounds. These include the therapeutic antidepressants, psychostimulants, and anticonvulsants, as well as the deleterious cocaine, cathinone, and some amphetamine derivatives (1). LeuT, a nonpolar amino acid transporter (2) and prokaryotic NSS homolog from the hyperthermophilic, chemolithotrophic eubacterium Aquifex aeolicus (3), has provided remarkable mechanistic insight into the molecular determinants of transport activity of its eukaryotic counterparts (4). Such understanding has been facilitated by a combination of high-resolution crystal structures (2, 5–7), computational modeling (8), and molecular dynamics (MD) simulations (9–11) integrated with substituted cysteine accessibility measurements (SCAM) (12), as well as elegant solution spectroscopic studies such as single-molecule FRET (smFRET) (13, 14), electron paramagnetic resonance (EPR), and double electron–electron resonance (DEER) (15, 16).
Akin to all secondary transporters, LeuT exists in a dynamic equilibrium between ensembles of outward- and inward-open conformations, with its substrate and ion binding sites alternately accessible to either side of the membrane bilayer (Fig. S1). However, this equilibrium can be shifted to favor one of these conformations by changing the conditions (4). In the presence of Na+ and absence of substrate amino acid, for example, LeuT favors an outward-open conformation (6, 9, 12, 16). This conformation is characterized by considerable solvent accessibility to the extracellular vestibule and surrounding residues [transmembrane helix 1b (TM1b), TM3, and EL4] with concomitant closure of the intracellular gate involving interactions between residues R5, Y268, and D369 from TMs 1a, 6b, and 8, respectively (2, 6). Disruption of this intracellular gate by mutating a universally conserved tyrosine to alanine at position 268 in LeuT (Y268A) favors the inward-open conformations of the protein (13, 15), and similar results are observed for the DAT intracellular gating residue mutant Y335A (17, 18). In fact, Y268A was one of three mutations used to crystallographically “trap” LeuT in an inward-open conformation (6). With the aid of these mutations, progression to the inward-open state was characterized by conformational changes involving primarily the “bundle” (8, 19) helices (TMs 1, 2, 6, and 7), with the “scaffold” (8, 19) (TMs 3–5 and 8–10) remaining relatively static (Fig. 1A). Concurrently, the opening of the intracellular gate was shown to render the cytoplasmic ends of the transmembrane helices, especially TMs 1–2 and 5–8, more solvent accessible (6, 8).
Fig. S1.
Schematic of the conformational cycle of LeuT (green). Substrate, sodium ions, and proton are depicted as a blue hexagon, red circles, and a black circle, respectively.
Fig. 1.
Overall structural comparison and peptide coverage. (A) Outward-open LeuT structure (PDB ID code 3TT1; gray) superimposed onto inward-open LeuT (PDB ID code 3TT3; colored) using TMs 3, 4, 8, and 9 [the so-called “hash motif” (83)]. Color correlates to positional change (0–19 Å) in the Cα atoms of aligned residues. (B) Inward-open LeuT structure colored to represent the peptides monitored in this study. Color reflects redundancy of the amino acid in the final peptide list.
Although the existing LeuT literature reflects groundbreaking advances, it suffers from some major shortcomings. Aside from the fact that the resolution of existing techniques are limited to local distance or accessibility changes that must then be extrapolated to the entire protein, almost all of these studies have been conducted in detergent micelles, which can be poor substitutes for the membrane (20). For example, the affinity of LeuT for the substrate Ala, and the Bmax for both Ala and Leu are at least 1.5-fold greater in a lipid bilayer than they are in the detergent n-dodecyl-β-d-maltoside (DDM) (21), and TM1a adopts a different orientation in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes than it does in DDM (22). Lipids, especially cholesterol and sphingolipids, seem to play an even more significant role for eukaryotic NSS members, with specific lipids markedly altering transporter conformational dynamics to the point of modulating how a drug, substrate, and/or ions interact with the protein (23–26). Moreover, the mere presence of detergent may have unforeseen consequences (27). In particular, n-octyl-β-d-glucoside (β-OG) binds in the extracellular vestibule of LeuT (28, 29), presumably inhibiting activity (29), and the mild, widely used detergent DDM appears to influence substrate-binding properties depending on its concentration (2 versus 6 mM) (30). Hence, it is critical that such investigations be carried out in a more physiologically relevant membranous medium. The second issue with published LeuT studies is that conformational dynamics have been monitored exclusively via cysteine accessibility, smFRET, EPR, and DEER. Although such methods are powerful, they require covalent modification of dozens of strategically placed cysteines with methanethiosulfonate reagents (SCAM) (31), fluorophores (smFRET) (32), or spin labels (EPR and DEER) (33, 34) on a fully active, cysless protein target. Constructing such a variant is an arduous process that has thus far been unattainable for mammalian NSS members. Even for an endogenously cysless protein like LeuT, introduction of nonnative cysteines demands that the functional and structural fidelity of each mutant be scrutinized before use.
Here, we overcome these experimental obstacles by gauging global conformational dynamics via hydrogen–deuterium exchange coupled with mass spectrometry (HDX-MS) on LeuT reconstituted into phospholipid bilayer nanodiscs and interpreting the results with the help of MD simulations. To test the validity of our strategy, we focused on two conditions under which LeuT should adopt the most divergent conformational ensembles. Significantly, these conformations include those stabilized by psychoactive antagonists in LeuT’s mammalian counterparts (35, 36). HDX is an isotopic labeling technique in which amide hydrogens in the peptide backbone become “exchanged” for deuterium upon incubation in D2O-containing buffer. The solvent-exposed regions readily exchange at the earliest time of incubation, allowing HDX to probe the structure of a protein. Furthermore, local fluctuations result in transient exposure of otherwise unexchangeable amide hydrogens. Over time, these transient exposure events result in increasing deuterium incorporation at any given site, a direct measurement of conformational dynamics. When HDX is coupled with proteolytic digestion and MS, the extent of deuterium incorporation can be localized to specific peptides (37). Furthermore, supplementing the analysis with MD simulations of hydrated protein structures embedded in a lipid bilayer and under related conditions can pinpoint individual residues and dynamic behaviors responsible for specific observations, more directly than would be possible by comparison with static X-ray crystallographic structures. Here, for the NSS family member LeuT, we demonstrate major differences in TM1a, TM7, EL2, and EL4, when comparing conditions that favor outward- or inward-facing conformations. Importantly, the deuteration rates predicted from MD simulations of inward and outward conformations mirror the trends observed in HDX-MS data, furnishing singular insights into the conformational flexibility of unmodified LeuT and, by extension, its eukaryotic counterparts, in a more native environment.
Results
Substrate Binding to LeuT-WT and LeuT-Y268A in Nanodiscs.
To investigate the HDX signature of the outward- and inward-facing conformations, we used two LeuT variants: LeuT-WT and -Y268A. As mentioned above, the equilibrium of Leu-WT is biased toward an outward-open conformation in the presence of Na+ alone, that is, in the absence of substrate. By contrast, the Y268A mutant biases the equilibrium toward the inward-facing conformation (15). These two constructs were each introduced into nanodiscs. Although it is not possible to evaluate sodium-dependent substrate ([3H]Leu or [3H]Ala) transport in such a nonvesicular preparation, sodium-dependent [3H]-substrate binding can be assessed to ensure that the protein is correctly folded and inserted into the bilayer. We therefore examined the ability of both LeuT-WT and -Y268A to bind [3H]Leu, using a previously published scintillation proximity assay (SPA)-based protocol (21), differing only in that LeuT was now reconstituted into biotinylated nanodiscs. These data confirmed that, in the presence of 50 mM sodium, both variants can indeed bind [3H]Leu with similar Bmax values but with vastly different dissociation constants (Kd) (46 versus 916 nM for LeuT-WT and -Y268A, respectively) (Fig. S2). The ∼20-fold lower affinity of the Y268A mutant for Leu most likely reflects its conformational bias toward inward-open conformations.
Fig. S2.
Saturation binding of [3H]Leu to nanodisc-reconstituted LeuT-WT (green circles), -Y268A (orange), and empty nanodiscs (blue triangles). Data were fit to a rectangular hyperbola, as implemented in GraphPad Prism 7.01. Error bars represent the SEM for each data point over three independent experiments.
Peptide Mapping and Coverage of LeuT Peptides via MS.
Having established that nanodisc-reconstituted LeuT was correctly folded, we next tested whether peptides obtained upon proteolysis of LeuT-WT could be identified by MS. Data collected from multiple peptide identification runs were used to generate a coverage map for LeuT peptides. Overall, MS identified 65% of the protein length (amino acids 1–515) with an average redundancy of 2.04 (Fig. S3). To the best of our knowledge, this is the highest coverage so far reported for an integral membrane protein incorporated into nanodiscs (38–40). The factor responsible for the greatest increase in coverage was reduction of membrane scaffold protein (MSP)-peptide contamination, specifically by trapping biotinylated MSP onto neutravidin beads upon nanodisc disassembly. Moreover, this step helped minimize phospholipid interference during digestion and liquid chromatography (LC) capture, thereby improving MS detection of LeuT peptides. Importantly, segments of LeuT previously implicated in conformational transitions (6, 13–16) (TM1a, TM1b, TM6a, TM6b, TM7, TM8, EL2, and EL4) (Fig. 1 A and B, and Fig. S3) were more readily detected by MS than the rest of the protein. Thus, confident that MS was able to detect the protein segments thus far reported to play a role in the transport cycle, we proceeded to carry out HDX experiments to characterize deuterium uptake rates in these regions, with the aim of identifying uptake patterns unique to the two different transporter conformational ensembles under native-like conditions.
Fig. S3.
LeuT peptides observed during sequence identification runs mapped onto the amino acid sequence of the protein. Peptides are represented as blue bars and aligned to their relative position along the primary sequence.
Overall Conformational Signatures of LeuT in Lipid Nanodiscs as Revealed by HDX-MS.
Comparison of HDX-MS data for LeuT-WT and LeuT-Y268A in the presence of saturating sodium allowed us to identify elements of the protein whose accessibility or conformational ensembles differ between these outward- and inward-favoring conditions. In particular, peptides encompassing the N-terminal peptide, TM1a, EL2, the cytoplasmic end of TM7, and surrounding the extracellular vestibule (TM1b, EL4, and TM6a), all showed significant differences in deuterium uptake. Fig. 2 shows deuteration kinetics for a selection of these peptides. The difference in deuterium exchange rates between outward- and inward-favoring conditions (Δ%D) mapped from the N to the C terminus clearly highlights the distinct accessibility or conformational dynamics of the two LeuT variants (Fig. 3). Specifically, the extracellular entrance (TM1b, EL2, EL3, and EL4b) was more heavily deuterated in outward-favoring LeuT-WT, whereas the N-terminal peptide, TM1a, the intracellular end of TM7, the small extracellular loop following TM7, and EL4a, all exhibited greater deuteration in inward-favoring LeuT-Y268A (Figs. 2 and 3).
Fig. 2.
Deuterium uptake kinetics of representative peptides from LeuT. Plots depict data from the outward-favoring (green) and inward-favoring (orange) conditions for peptides across LeuT. The structure (center) is colored to highlight the locations of the peptides in TM1a (blue), EL2 (purple), TM7 (brown), EL4a (yellow), the EL4ab loop (orange), and EL4b (red).
Fig. 3.
Difference in deuteration profiles of LeuT peptides between outward- and inward-favoring conditions. Bars represent the difference in total deuteration [over four time points, represented as lines: 10 s (cyan), 60 s (blue), 600 s (purple), and 7,200 s (black)], with negative values (orange) indicative of higher deuteration in the inward-favoring condition. Gray regions indicate 98% confidence interval cutoffs (Materials and Methods) for individual time points (dark gray) and the total (light gray). NT, N terminus; CT, C terminus.
Slow Conformational Dynamics in TM7 and EL2.
Amide-H/D exchange events are typically classified as falling within one of two distinct kinetic regimes, EX1 or EX2. EX2 delineates the kinetics of protein dynamics that are faster than the chemical rate of hydrogen to deuterium exchange for peptide(s) residing within a region of the protein. Although the amplitudes of the motions contributing to EX2 exchange may span a wide range, these motions are generally rapid and uncorrelated. Less common is exchange within the EX1 kinetic regime, in which protein movements are significantly slower compared with the chemical rate of exchange (41, 42). EX1 kinetics has traditionally been associated with cooperative motions that simultaneously expose multiple adjacent amide hydrogens for exchange, which might occur, for example, by local unfolding. In HDX-MS measurements, EX1 kinetics is generally characterized by a signature bimodal isotopic distribution in the mass/charge ratio, where longer deuterium incubation periods result in the exchange-protected (low mass) and exchange-prone (high mass) envelopes gradually shrinking and accumulating, respectively. This change in isotopic distribution reflects the increasing proportion of protein that has sampled an exchange-prone state of such a slow, cooperative conformational change (41, 42). Such kinetic behavior was observed for peptides at the intracellular end of TM7, that is, the fragment containing amino acids 278–285, hinting that these peptides or their packing with neighboring protein segments underwent conformational changes with slow kinetics (Fig. 4 A and C). Interestingly, this EX1 behavior was observed only in the inward-favoring condition (Y268A). These observations of cooperative “unfolding” (or repacking) of the region involving TM7 are concordant with previously reported DEER data, indicating that movement of TM7 occurs during opening and closing of the intracellular gate (15).
Fig. 4.
EX1 kinetics of EL2 and TM7. (A) Superimposed structures of outward- and inward-open conformations of LeuT highlighting the locations of EL2 and TM7. (B and C) Mass over charge spectra (black lines) measured without deuteration (UD) and after deuteration for four different time windows, for peptides 142–148 (EL2; B) and 278–285 (TM7; C) arranged vertically to depict the difference in progressive deuteration in the outward- (WT; Left) and inward-favoring (Y268A; Right) conditions, respectively. The total isotopic peak (blue) was decomposed into protected (green) and unfolded (red) fractions, when applicable.
Similar EX1-type deuterium uptake kinetics was also observed for residues 142–148 (EL2; Fig. 4B), which are involved in closure of the extracellular side, when EL4 packs more closely against them (Fig. 4A). Together, these observations demonstrate that differences in conformational ensembles could be detected using HDX-MS and provide clues about the dynamics of areas of the transporter that undergo concerted conformational transitions.
Agreement Between Experimental and in Silico-Predicted Deuterium Uptake.
The aforementioned EX1-type kinetics of EL2 and TM7 is likely to reflect local unfolding on a relatively slow timescale. By contrast, differences in the EX2-type HDX results for different conditions may be more reflective of faster-scale fluctuations affecting the solvent accessibility of the peptide backbone under those conditions. We therefore hypothesized that interpretation of these data could be aided by comparison of ensembles of structures generated with MD simulations (43, 44) starting with X-ray crystallographic structures of different conformations of LeuT. The outward- and inward-open conformational ensembles of LeuT were mimicked in silico using MD simulations of the following, respectively: the substrate-free, sodium-bound, outward-open structure [Protein Data Bank (PDB) ID code 3TT1] after reversing the Y108F mutation (12); and the substrate-free, inward-open, structure (PDB ID code 3TT3) after reversing the modifications at the Na2 site (T354A and S355A) and TM7 (K288A) (10), but maintaining the intracellular gate mutant Y268A. In each case, the protein was embedded in a hydrated lipid bilayer. Analysis of multiple ∼450-ns-long trajectories revealed that the root-mean-squared deviation (rmsd) from the X-ray structure of the Cα atoms in the transmembrane helices is only 1.0 ± 0.1 Å for the outward-facing system and 1.7 ± 0.1 Å for the inward-facing system, each averaged over the last 100 ns of three independent trajectories, indicating the protein structure was stable.
To compare the in silico and in vitro data as directly as possible, we computed the expected extent of deuterium incorporation for each of the peptides based on the so-called protection factor, which is an empirical parameter reflecting the degree to which each amide proton forms hydrogen bonds and is surrounded by other protein groups (44) (Materials and Methods). However, this analysis approach was developed for water-soluble proteins, and therefore it was unclear whether it could reasonably be applied to simulations of membrane proteins, or whether its application to membrane proteins would require timescales longer than ∼100 ns (44) to account for differences in dynamics of the protein and its environment. In particular, the residue protection factor is computed as an ensemble average, contingent on the environment as well as thermal fluctuations, and thus also on trajectory length. Therefore, for each simulation, we calculated the protection factor as a function of extending the length of the trajectory up to ∼500 ns. The protection factor for each of the independent trajectories stabilized after ∼200-ns simulation (Fig. S4A), indicating that this timescale was both required and sufficient to obtain an ensemble of LeuT conformations whose hydrogen bonding and packing were adequately sampled. The small variation between the three trajectories underscores the additional conformational sampling achieved by the use of multiple independent trajectories for direct comparison with experimental data.
Fig. S4.
Calculated protection factors for the MD simulations of LeuT. (A) Convergence of the total protection factor over all residues in each simulation (Materials and Methods) was computed as a function of the input simulation time window, for each of three trajectories (red, green, blue circles), and as a mean and SD of the three (black circles) for either outward-open (Upper) or inward-open (Lower) conformations. For reference, the corresponding total protection factors for the input X-ray structures are 60.9 × 108 (3TT1; outward-open) and 7.6 × 108 (3TT3; inward-open); the higher degree of protection presumably reflects the lack of thermal fluctuations and dehydration of the crystal. (B) Location of the least (red) and most (blue) protected regions in simulations of the outward-open (Left) or inward-open (Right) conformations of LeuT. The protection factor for individual residues was computed using all three trajectories for their full lengths, and the log of the protection factor was mapped onto the input structures.
As expected, the residues with the smallest protection factors were the most dynamic and exposed to aqueous solution (Fig. S4B). Importantly, for the peptides detected by MS, the predicted deuterium uptake based on these protection factors for the two simulated states of LeuT followed the same trend as the observed uptake in both outward-favoring (WT) and inward-favoring (Y268A) conditions (Table S1, Fig. 5, and Fig. S5). For example, when we extrapolated the computed protection factors into values of expected deuterium exchange after 10 min of exposure, the predicted values correlated with the experimental data for 21 peptides in the outward-favoring condition with Pearson’s correlation coefficient of 0.84 (Table S1). For reference, when using only the X-ray crystal structure (3TT1; inward-open) to predict deuterium uptake, the corresponding correlation coefficient is only 0.47, emphasizing the requirement for an ensemble average of conformations upon which to compute the protection factors (44).
Table S1.
Pearson’s correlation coefficient between predicted and measured HDX rates over 21 peptides
| t, s | ||||
| Simulation setup | 10 | 60 | 600 | 7,200 |
| Outward | 0.81 | 0.84 | 0.84 | 0.75 |
| Inward | 0.63 | 0.76 | 0.78 | 0.64 |
Predictions were obtained for different extrapolated time points, from 10 s to 2 h, to correspond with the experimental measurement time window (t). Data are for “Outward,” that is, HDX-MS of the outward-favoring condition (LeuT-WT) compared with simulations of the outward-open structure (3TT1), and “Inward,” that is, HDX-MS of inward-favoring condition (Y268A) compared with simulations of the inward-open structure (3TT3-Y268A).
Fig. 5.
Agreement of deuterium uptake trends over 21 LeuT peptides between in vitro (green and orange) and in silico (blue) HDX experiments. Left and right panels depict data for deuterium uptake for peptides in the outward- and inward-favoring states of the transporter, respectively, compared with simulation data starting with the outward- and inward-open states, respectively.
Fig. S5.
Comparison of deuterium uptake between in vitro (Exp) and in silico (Sim) experiments represented as heat maps on crystal structures of LeuT in the outward-favoring (A) and inward-favoring (B) conformations for the undeuterated (0 s) system and after four different deuterium exposure time points.
The overall agreement between the predicted and measured deuterium uptake levels provided support for the assumption that >200-ns-timescale simulations recapitulate many important features of the solvent accessibility of the ensembles being measured experimentally (Figs. S4 and S5), and engender confidence that the computation of the predicted deuterium fraction is a reasonable strategy for membrane proteins. For example, the simulation data correctly predicted overall higher deuteration of the N-terminal segment (peptides 1–12, 1–14, and 1–16), and EL4b (residues 325–331) as well as lower deuteration in TM1b (residues 29–34), and EL4a (peptide 306–313), when comparing outward- to inward-facing systems (Fig. 5). Thus, MD simulations may be useful for providing molecular detail to the measured deuteration and to differences between the two conformations.
Conformational Dynamics of TM1a, the N-terminal Peptide, and TM7.
A striking feature of the inward-open crystal structure of LeuT is the seemingly unrestrained repositioning of TM1a into the predicted hydrophobic core of the membrane bilayer, relative to the outward-facing structures (6) (Fig. 6A). Indeed, the extent of TM1a movement has been a source of contention in the field given that the crystal conditions contained mostly detergent and only a minute quantity of lipid [1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE)], and that biophysical and computational studies have indicated a more restrained tilt of the helix (10, 15, 22, 45). Our HDX-MS data demonstrate that TM1a (amino acids 17–28) as well as the attached N-terminal peptide (amino acids 1–16) were less protected against deuterium exchange under the inward-favoring conditions and thus apparently free to sample a larger conformational space with greater solvent accessibility than was available under the outward-favoring conditions (Figs. 2, 3, and 5, and Fig. S6). MD simulations also captured this difference in that the predicted deuteration was significantly higher for the N-terminal peptide in the inward-open system (Fig. 5 and Fig. S4). Surprisingly, however, there was no significant increase in the predicted deuteration for residues in TM1a, in contrast to the increase predicted for the N-terminal peptide. Nevertheless, TM1a helix was observed to explore a wider range of tilt angles in simulations of the inward-open state (Fig. 6B) relative to those of the outward-open state, indicating greater flexibility. The average value of this tilt angle was smaller than that obtained for the crystal structure (Fig. 6B), consistent with free-energy calculations (10, 22), possibly reflecting the difference between lipid and detergent environments. Importantly, directly quantifying aqueous accessibility of individual amino acids identified several residues in TM1a for which either the backbone or side chain exposed a larger surface area to water during the simulations of the inward-open structure, consistent with an increased propensity for deuteration (Fig. 6B and Fig. S6 B and C). Of particular note is residue L14, whose increased solvent accessibility is consistent with the higher measured deuteration of residues in peptides containing residues 12–14 and 12–16 in the inward-favoring conditions (Fig. 3 and Fig. S6B), as well as M18 and N21 (Fig. S6 A and C), whose increased solvent accessibility matched the higher measured deuteration of peptides covering residues 17–28 (Figs. 2 and 3, and Fig. S6B). In this way, the simulations also help narrow the segment responsible for measured changes from ≥6-residue-long peptides down to individual amino acids.
Fig. 6.
Behavior of TM1a in simulations of inward- and outward-facing LeuT. (A) Outward-open LeuT structure (PDB ID code 3TT1; green) superimposed onto the inward-open structure (PDB ID code 3TT3; red-orange) highlighting TM1a as opaque cartoon helices. (B) Angle of TM1a relative to the membrane normal (z axis) during MD simulations of the two structures, shown as the time dependence for each of three trajectories of the outward- (black, red, cyan lines), and inward-facing conformations (green, orange, blue lines), sampled every 100 ps, and compared with the values computed for the X-ray structures (red diamonds at t = 0). Data sampled every 10 ps are shown in gray. For each time frame, the protein was superposed onto the initial structure using the Cα atoms of TM helices 3, 4, 8, and 9 (the hash domain); the starting structure, in turn, was aligned to the approximate membrane plane according to OPM (Materials and Methods). (C and D). Snapshots of LeuT in outward- (green; C) and inward-open (orange; D) states, embedded in a hydrated DMPC bilayer (spheres). Protein molecules are depicted as ribbons and surface representation, with the surrounding water molecules shown as blue sticks.
Fig. S6.
Aqueous accessibility of residues in the cytoplasmic pathway of LeuT during simulations of the outward- and inward-open structures. (A) Simulation snapshots from the end of the trajectories, viewed from along the membrane plane and with the periplasmic side toward the Top. The water volume computed as the occupancy over the last 50 ns of three trajectories is shown as purple density at 30% occupancy level. The protein is shown as cartoon helices, with TM1a (blue) and TM7 (brown) highlighted. Helices in the scaffold (TMs 3, 4, 8–12) are omitted for clarity. Amino acids whose solvent accessibility increases in the simulations of the inward-open structure are shown as sticks, except for nonpolar hydrogen atoms. (B) Relative contribution of amino acids at the N terminus and in TM1 toward the increased deuteration observed in the inward-favoring condition. Graph shows difference in #D between the two conditions for three overlapping peptides [residues 1–12 (orange), 1–14 (brick), and 1–16 (red)] over four time points. Inset shows deuteration kinetics for peptide 18–28 (purple bar) for the outward-open (green line) and inward-open (orange line) states, respectively. (C) Surface area of the backbone (Top) or side chain (Bottom) of each residue that is accessible to water during simulations of the outward-open (green) and inward-open (orange) states, computed as the mean and SD over all snapshots taken every 100 ps from all three trajectories. Residues of TM1 (blue) and TM7 (brown) that are helical in the outward-facing structure (3TT1) are highlighted. Residues in TM1 and TM7 whose solvent-accessible surface area (SASA) increases significantly in the inward-open state are indicated with arrows.
In TM7, residues in its ostensibly buried segment (S278 and A282) also became more accessible to water in simulations of the inward-facing structure, partly due to separation of TM1a and TM6 away from TM7 (Fig. S6). This finding is concordant with increased HDX measured in peptides 278–282, 278–285, and 278–289 in inward-favoring LeuT-Y268A compared with outward-favoring LeuT-WT (Fig. 3).
The above analysis of the solvent-accessible surface area indicates that the simulation of the inward-facing Y268A mutant did capture the exposure of TM1a and TM7 implied by the experimental measurements for Y268A, suggesting reasonable overlap between in silico and in vitro ensembles. What then explains the underestimation in the predicted deuteration exchange at these segments (Fig. 5)? We posit that this discrepancy may reflect limitations in the approach used to translate MD trajectories into predicted deuteration for helices that buttress narrow aqueous pathways in membrane regions, although it is also possible that the HDX kinetics in this region are slower than the simulation timescale.
Insights into the Conformational Dynamics of EL4.
The peptides that include EL4a (amino acids 306–311, 306–313, 312–324, and 314–324) all exhibited a significant reduction in deuterium uptake under the inward-favoring versus outward-favoring conditions (Fig. 3), whereas residues in EL4b (amino acids 325–331) exhibited the opposite pattern. The MD trajectories mirrored these findings. Specifically, peptides 306–313 and 312–314 of EL4a were slightly more protected in the simulations of the inward-open structure, whereas peptides in EL4b became less protected (residues 325–331; Fig. 5). These observations uphold expectations based on the relative orientations of EL4a and EL4b seen in the inward-open structure where the V-shaped tip of EL4 dips into the extracellular vestibule, rendering EL4a more exposed to the extracellular milieu, while concomitantly shielding EL4b by virtue of the latter’s proximity to EL2 and TM2 (6). Analysis of the trajectories revealed that this difference in predicted deuterium uptake reflected not only the packing of EL4 against its neighboring elements but also changes in, and increased flexibility of, backbone dihedral angles (Fig. 7 B and D), most strikingly for A319, which resides in the short loop connecting EL4a to EL4b.
Fig. 7.
Altered dynamics of EL4 in LeuT under outward- and inward-favoring conditions. (A) Mass over charge spectra measured without deuteration (UD) and after deuteration for four different time windows, for a peptide in EL4 comprising residues 312–324, indicating a unique population of more highly deuterated peptides in inward-favoring (Right) relative to outward-favoring LeuT (Left). The total isotopic peak (blue) is decomposed into protected (green) and unfolded (red) fractions, when applicable. (B) Position of EL4a and EL4b in the outward-open (orange) and inward-open (green) structures of LeuT. The position of A319 and its neighbor G318 (ball-and-sticks) are shown in detail in the Inset. (C) Fraction of peptide 312–324 deuterated (unfolded) as a function of incubation time for LeuT-WT (orange) and -Y268A (green) LeuT. (D) Backbone (θ, Upper, and ψ, Lower) dihedral angles in A319 in the EL4ab loop during MD simulations of the outward-open (3TT1; Left) and inward-open structures (3TT3; Right). For each simulation system, three independent trajectories are shown (black, red, and cyan points) sampled every 100 ps. For reference, the θ, ψ values of the X-ray structures are as follows: –58.3°, –46.7° in 3TT1; and –84.0°, 141.2° in 3TT3.
Analysis of experimentally determined deuterium uptake kinetics for residues in the V-shaped tip of EL4 (amino acids 312–324; Fig. 6B) under inward-favoring conditions unveiled a bimodal isotopic distribution in the mass/charge ratios (Fig. 7B). However, detailed inspection of the mass spectra (Fig. 7 A and B) revealed that the exchange-protected envelope did not diminish, suggestive that Y268A adopts two noninterconverting conformations in this region. Quantification of isotopic distribution envelopes for this peptide revealed that ∼30% of the peptide population remained protected throughout the deuterium exposure (Fig. 7C). Curiously, this behavior was absent for the same peptide under outward-favoring conditions (Fig. 7A). It should be noted that for a few other peptides, this pattern of “static” (or very slow) bimodal behavior was observed in both inward and outward favoring conditions, with notable exceptions being the peptide encompassing EL4 (amino acids 312–324; Fig. 7A) and another in TM7 (amino acids 278–289) for which the protected envelope remained static exclusively in the outward-favoring condition (Fig. S7 and Table S2). It is also worth noting that peptides displaying such static bimodal behavior colocalized, primarily on the extracellular side of the transporter (Fig. S7).
Fig. S7.
Location (blue) of peptides whose spectra exhibited a static double-envelope behavior in either outward-favoring (green) or inward-favoring (red) condition, are mapped onto the X-ray structures of outward- and inward-facing conformations, respectively.
Table S2.
Envelope progression of peptides exhibiting EX1/EX1-like behavior
| Amino acid | Presence of static peak | |||
| Start | End | Region | Outward-open | Inward-open |
| 29 | 34 | TM1b | Yes | Yes |
| 142 | 148 | EL2 | N/A | No |
| 278 | 285 | TM7 | Yes | No |
| 278 | 289 | TM7 | Yes | No |
| 297 | 302 | EL4 | N/A | N/A |
| 297 | 305 | EL4 | Yes | Yes |
| 312 | 320 | EL4 | N/A | Yes |
| 312 | 324 | EL4 | N/A | Yes |
| 314 | 320 | EL4 | N/A | Yes |
| 325 | 331 | EL4/TM8 | Yes | Yes |
Discussion
NSS members are integral membrane proteins that play a crucial role in terminating synaptic transmission and in shaping the duration and magnitude of synaptic signaling. They are the targets of numerous psychoactive agents, and their dysfunction is implicated in multiple neuropsychiatric illnesses (1). Large-scale conformational changes are integral to their function, and these movements are modulated by interaction with substrates, inhibitors, ions, presynaptic proteins, and lipids. Because of their extraordinary clinical importance, it is essential to build a solid mechanistic grasp of their conformational dynamics in their native lipidic environment.
The objective of this study was to develop a strategy that could delineate the conformational signatures of two divergent conformations of an unlabeled NSS protein in a membrane-like milieu. To achieve these goals, we incorporated LeuT, a thermostable prokaryotic NSS homolog, into lipid bilayer nanodiscs. To circumvent the need to label specific residues, we monitored the conformational hallmarks of LeuT using HDX-MS, a technique that has previously been used to probe the conformational dynamics of other membrane proteins (46–48). We biased the conformational equilibrium to more outward-favoring orientations by adding saturating Na+ to WT LeuT. To shift the equilibrium toward inward-favoring conformations, we capitalized on the well-characterized Y268A mutant. To avoid complications related to removal of Na+ and to permit direct comparison with the outward-favoring condition, we used assay buffer with identical components, including 100 mM NaCl. Despite the fact that Na+ unambiguously shifts the equilibrium of WT LeuT toward outward-favoring orientations, the same is apparently not true for Y268A (15). Specifically, the distance distributions between spin labels on pairs of residues in TM9 and TM1a, or in TM9 and TM5, used to characterize the inward-facing conformation, do not change for Y268A in the presence and absence of 200 mM NaCl (15). On the other hand, smFRET data suggest that Na+ can modulate the inward-outward distribution of Y268A to some extent (13). Thus, Na+ is apparently able to modulate the dynamics of Y268A, and yet cannot completely overcome its bias to inward-favoring conformations. Indeed, the HDX pattern of the Y268A variant reported here, consistent with an inward-facing conformation, is in harmony with the latter finding.
Broadly speaking, transition from the outward- to inward-open conformation in LeuT involves (i) occlusion of the extracellular vestibule, obstructing access to the substrate-binding site, and (ii) opening of the cytoplasmic pathway, partly facilitated by the untethering of the N-terminal peptide and TM1a from the scaffold (6, 12, 49). This study provides support for the notion that these global changes, with the same key players, which were previously described predominantly in detergent micelles, also occur in a lipid bilayer. Both HDX-MS and MD data for amino acids along TM1 clearly demonstrate the larger conformational space available to the N-terminal peptide and TM1a in inward-favoring versus outward-favoring conditions, albeit with a smaller average tilt angle than was reported in the corresponding inward-facing crystal structure (6) (Fig. 4). Note that crystallographic capture of the inward-open conformation of LeuT required multiple mutations in addition to Y268A at the cytoplasmic gate, as well as a conformation-specific antibody (6). One or more of these modifications may contribute to the distinct nature of TM1a in the MD simulations (10) in addition to the bilayer environment (11).
We note that, to the best of our knowledge, the simulations of the inward-facing conformation of LeuT-Y268A presented here are unique, because all previous studies either examined the inward-facing conformation after restoring the missing Tyr at position 268 (10, 22, 45, 49) or considered the allosteric effect of the Y268A modification in the outward-occluded conformation (11). Although the available evidence shows that the Y268A modification strongly affects the ability for LeuT to stabilize outward-facing conformations and to allosterically detect ligand binding in those conformations (11), comparison of our simulation data with that reported for previous studies (10, 22) revealed no obvious difference due to the Y268A modification in the nature of the inward-facing conformations, presumably because position 268 was entirely solvent exposed, and therefore unable to mediate direct interactions. Nevertheless, free-energy calculations could be used in the future to help rule out an effect of Y268A, and of other modifications used in such studies, on specific features of the inward-facing conformations of LeuT.
The overall pattern of measured deuterium uptake was well captured in predictions from MD simulations, as were the increases in dynamics and accessibility of the N-terminal peptide and EL4 identified experimentally. However, differences in the behavior of TM1a and TM7, both of which are accessible to water via a narrow aqueous pathway, and in contact with lipid, were not reflected by changes in predicted deuterium uptake. Although beyond the scope of the current study, it will be of interest to explore whether this discrepancy reflects a limitation of the “protection factor” descriptor for such pathway-lining regions, which are of particular importance in integral membrane proteins, or whether the relative dynamics are simply inherently slower than the simulation timescales. Nevertheless, it is encouraging that the molecular simulations on timescales of ∼200 ns show good convergence of the protection factors and that the overall correlation with the experimental data are high, despite the inherent differences between the in vitro and in silico systems.
In other regions of the protein, slow, EX1-type kinetic behavior for peptides belonging to EL2 and TM7 illuminate their structural plasticity. The observed EX1 kinetics data provide unprecedented insights into LeuT conformational dynamics that cannot be gleaned from either solution spectroscopy or static crystal structures. Another interesting feature of the HDX-MS data is the presence of a static bimodal isotopic envelope distribution for a selection of peptides. These observations suggest local conformational heterogeneity that may reflect preferential stabilization of certain conformations by the lipid nanodisc environment (50). Indeed, two recent studies have demonstrated disparate behavior of transporters in lipids versus detergent. First, Sohail et al. (22) reported different distributions for the N-terminal segment of LeuT in detergent micelles compared with POPC liposomes, as measured by lanthanide-based resonance energy transfer and in agreement with MD simulations. Second, Martens et al. (51), in a spectroscopic study of the proton-coupled multidrug antiporter LmrP, demonstrated that an inward-facing conformation was preferentially stabilized when the protein was incorporated into nanodiscs rather than solubilized in detergent. As such, the local heterogeneity reported by this static bimodal behavior may reflect conformations of LeuT that are stabilized upon incorporation into nanodiscs. However, measurements of HDX patterns of LeuT reconstituted into both lipidic and detergent environments will be needed to directly compare the effect of detergent on its conformational dynamics.
This study provides a probe-independent, global view of the dynamics of a membrane-bound transporter within a lipid bilayer, interpreted in atomic-level detail by integration with molecular simulations. Going forward, such data will be of enormous importance in understanding the relevance both of the snapshots provided by crystal structures as well as of information about local protein environment provided by other biophysical techniques such as smFRET and EPR. This success represents a crucial leap forward on the road to probing the dynamics of the more clinically relevant mammalian NSS members such as SERT and DAT, whose activities are heavily influenced by the specific properties of surrounding lipids and where retention of “wild-type” levels of activity in cysless mutants has not yet been realized. Furthermore, with these tools, we will now be able to delve into the effects of, for example, inhibitor binding as well as the dynamic sequelae of disease-associated polymorphisms, especially those located outside of canonical drug binding sites and/or facing the lipid bilayer, without having to mutate and/or otherwise modify the protein.
Materials and Methods
Protein Preparation.
MSP.
MSP1E3D1 was expressed in Escherichia coli BL21 (DE3) cells and purified as described (21). Following proteolytic cleavage of the polyhistidine tag used for purification, MSP was biotinylated by incubating with a 20-fold molar excess of NHS-Sulfo-SS-biotin (Pierce) for 30 min at room temperature and then removing unreacted biotin with Zeba spin columns (Thermo Scientific) as per manufacturer’s instructions.
WT LeuT and the Y268A mutant (LeuT-WT and -Y268A).
LeuT-Y268A was generated with PCR-based site-directed mutagenesis and verified by DNA sequencing. Both LeuT variants, each with a C-terminal 8× histidine tag, were expressed in C41(DE3) cells and purified as previously reported (52) with some modifications. Briefly, membranes were washed three times in buffer A [20 mM Tris (pH 8.0), 200 mM KCl] containing 10 mM 1,4,7,10,13-pentaoxacyclopentadecane (15-Crown-5) (53) to ensure efficient removal of sodium and thereby any endogenously bound leucine (52). As an added precaution, sodium-free labware was used throughout. Purification was initiated by solubilizing the washed membrane in buffer A containing 40 mM DDM followed by Ni2+-affinity [HiTrap IMAC Sepharose FF (GE Healthcare)] and gel filtration [Superdex 200 10/300 GL (GE Healthcare)] chromatography in buffer A containing 1 mM DDM. The His tag was left intact to facilitate downstream nanodisc purification and radioligand binding experiments via SPA (21, 54). Purified protein was concentrated to 1 mg/mL and stored at −80 °C until use.
Phospholipid Preparation and Nanodisc Assembly.
The two purified LeuT variants were separately reconstituted into nanodiscs as described elsewhere (21) with some minor adjustments. Lipid stocks [POPC and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)] were prepared in chloroform and mixed in a 3:2 molar ratio to obtain a 40 mM final lipid stock. After the chloroform suspension had been dried under nitrogen gas, the thin lipid film was solubilized in buffer B [20 mM Tris⋅HCl (pH 7.4), 100 mM NaCl, 0.5 mM EDTA] containing 80 mM sodium cholate. LeuT:MSP:lipids were mixed at a molar ratio of 1:20:1,000 to initiate reconstitution of LeuT into the nanodiscs. After incubating on ice for 1 h, SM2-Biobeads [10% (wt/vol)] were added to the mix, and the tube was rotated at 4 °C overnight. LeuT-containing nanodiscs (LeuT-ND hereafter) were separated from empty nanodiscs by passing through Ni-NTA resin, washing with 10 column volumes of buffer B containing 20 mM imidazole, and eluted in the same buffer containing 300 mM imidazole. The nanodiscs were then concentrated and purified further on a gel filtration column (Superdex 200 10-/300 GL; GE Healthcare) in buffer B. Purity and concentration of the LeuT-nanodisc preparations were calculated with SDS/PAGE, as detailed previously (21, 38).
Leucine Binding Assay.
Saturation binding of [3H]Leu to both LeuT-nanodisc preparations was assessed by SPA as outlined (21). Briefly, LeuT-containing nanodiscs were first preincubated with Cu2+ chelating YSi SPA beads (Perkin-Elmer) in buffer C [150 mM Tris-Mes (pH 7.5), 50 mM NaCl, 20% (vol/vol) glycerol] for 2 h at 4 °C to allow capture onto the bead surface. The resulting mixture was then incubated with 10–1,500 nM [3H]Leu [specific activity, 109 Ci/mmol (PerkinElmer; NET460)] for 1 h at room temperature in glass tubes before being transferred into the individual wells of a 96-well white-wall clear-bottom plate (Isoplate-96; PerkinElmer) and read in a MicroBeta counter (PerkinElmer) in SPA mode until counts plateaued, indicating equilibrium had been reached. The assay was performed three separate times, each time in triplicate. Nonspecific binding was measured in the presence of 5 mM Ala. Counts per minute were converted to picomoles using a calibration curve relating counts per minute to a known concentration of radioactive substrate, accounting for the manufacturer-provided efficiency of the SPA beads (60%). Data were analyzed via nonlinear regression in GraphPad Prism 6.0.
Optimization of Peptide Coverage Map for Downstream HDX-MS Experiments.
LeuT-ND samples were concentrated in buffer B using 10-kDa-cutoff Amicon ultracentrifugal filters to obtain a final sample concentration of ∼20 μM. Peptide identification and corresponding coverage map of LeuT were obtained from undeuterated controls. A typical sample workflow involved diluting 10 µL of LeuT-ND (20 µM) into 90 µL of buffer B at room temperature followed by quenching with 0.8% formic acid, nanodisc solubilization, and pepsin digestion.
To maximize the number of peptides identified and determine the optimal experimental setup to achieve maximal capture of LeuT peptides, the following variables were examined: detergent type [sodium cholate, β-OG, maltosides (decyl- and dodecyl), and maltose neopentyl glycols (decyl and dodecyl) (55)]; detergent concentration; pepsin species (porcine versus Aspergillus), digestion conditions, brand (Thermo Fisher, Sigma, or POROS), and location [inline versus free (immobilized or batch) at different concentrations]; quench solution (0.8% formic acid in LC-MS grade water with or without various concentrations of guanidine HCl or acetonitrile) to facilitate efficient pepsin digestion; removal of MSP peptides with Neutravidin UltraLink beads (Thermo Fisher), varying both amount and duration; and removal of solubilized phospholipids with ZrO2 HybridSPE beads (Supelco), again varying both amount and duration.
HDX-MS Experiments.
Based on the above trials, the optimal sample scheme selected for HDX purposes was as follows: 10 µL of LeuT-ND (20 µM) was diluted in 90 µL of buffer B after which 100 µL of 0.8% formic acid (in LC-MS–grade water) containing 50% (wt/vol) Neutravidin Ultralink beads (Pierce) and 10 µL of 2.5 mM DDM were sequentially added. Subsequent to vortexing for ∼5 s, the sample was spun down through a 0.45-µm Spin-X microcentrifuge tube filter (Costar) for 30 s after which 10 µL of 1 mg/mL porcine pepsin (Sigma) was added to the flowthrough, mixed by vortexing for ∼5 s, and incubated on ice for 4 min. To remove solubilized phospholipids, 10 µL of 300 mg/mL ZrO2 HybridSPE-Phospholipid beads (Supelco) equilibrated in 0.8% formic acid were added and incubated on ice for 1 min. All steps after dilution were performed either on ice or at 4 °C to minimize back-exchange during the actual deuteration experiment (see below). The resulting mixture was spun down through a 0.45-µm Spin-X microcentrifuge tube filter for 30 s and then immediately injected into a Waters HDX nanoAcquity ultra-performance liquid chromatography (UPLC) system (Waters). Peptic fragments were trapped on an Acquity UPLC BEH 300 C18 peptide trap and separated on an Acquity UPLC HSS T3 C18 attached to an Acquity UPLC BEH C18 guard column. A 7-min, 5–35% (vol/vol) acetonitrile (0.1% formic acid) gradient was used to elute peptides directly into a Waters Synapt G2 mass spectrometer (Waters). MSE data were acquired with a 20- to 30-V ramp trap collision energy for high-energy acquisition of product ions and lock mass (Leu-Enk) for mass accuracy correction. Peptides were identified using the ProteinLynx Global Server 2.5.1 (PLGS) from Waters.
H/D exchange reactions were performed using the workflow outlined above except that 90 μL of buffer B was replaced by deuterated buffer B. All deuteration reactions were performed at 25 °C and quenched at various times (10 s, 1 min, 10 min, and 2 h) for both LeuT-WT as well as -Y268A. All deuteration time points and controls were acquired in triplicate. Deuterium uptake by the identified peptides over time was calculated with Waters’ DynamX 2.0 software. When considering all time points and both constructs, these conditions allowed for HDX analysis of 35 peptides (27% of the LeuT sequence, i.e., about one-half of the peptides detected by MS could be analyzed for deuterium exchange) (Fig. S3). Plots of the difference in deuterium uptake Δ#D(WT-Y268A) were generated for these peptides. Confidence intervals for the Δ#D of any individual time point were determined according to Houde et al. (56–59). Specifically, the 98% confidence interval for the Δ#D was determined to be ±0.33 deuterium atoms incorporated at any single time point, or ±0.66 deuterium atoms incorporated when considering the sum of the Δ#D over all four incubation time points. For peptides displaying bimodal spectra, the two peaks were deconvoluted using HX-Express2 (60). The deuterium level and relative intensity of each individual envelope were extracted, and the relative deuterium level of the exchange-protected envelope alone was used to compute Δ%(WT-Y268A) for the purposes of comparison with predicted deuteration based on MD simulations. The change in relative intensity of the unprotected peak (%U) as a function of time was used to ascertain whether the two species were interconverting.
To account for back-exchange, experiments with fully deuterated controls were performed. Specifically, LeuT in buffer A containing 1 mM DDM was lyophilized and then dissolved in D2O (99.9%; Cambridge Isotopes with 1 mM DDM), with the process being repeated twice. Ten microliters of deuterated LeuT were further incubated in 90 µL of buffer B containing 6 M guanidine-DCl for 2 h at 25 °C. The rest of the UPLC and MS procedure was unchanged. Out of the 35 peptides, 21 displayed a well-defined spectral isotopic envelope for the fully deuterated control. For these peptides, deuterium uptake was normalized as follows: , with mt, the centroid mass at incubation time t; m0, the centroid mass of the undeuterated control; and mf, the centroid mass of the fully deuterated control. The 98% confidence intervals were adjusted accordingly and were determined to be ±8%.
MD Simulations.
Simulations were carried out on LeuT monomers starting with two different structures: outward-open sodium-bound, or inward-open sodium-free, each embedded in a patch of dimyristoylphosphocholine (DMPC) bilayer, and hydrated with 100 mM salt solution. DMPC was selected based on hydrophobic matching with LeuT monomers (61). The simulations of outward-open LeuT have been described previously (12). Briefly, the starting point for the protein was PDB ID code 3TT1, with Na+ ions occupying both Na1 and Na2 sites; the Y108F mutation introduced into the crystallization construct was reconverted to WT Y108. Protonation states were assigned according to multiconformation continuum electrostatics calculations (62) performed on the corresponding X-ray structures (12). Thus, E112, E287, and E419 were protonated in both systems. E290 was deprotonated in the outward-open state (with sodium bound at Na1 and Na2) and protonated in the inward-open state (where sodium is not bound). The starting point for the inward-open system was based on PDB ID code 3TT3, but because of concerns over the position of TM1a, we used a protein conformation with the minimum free-energy conformation of TM1a based on umbrella sampling calculations of LeuT in a lipid bilayer environment, kindly provided by Prof. B. Schiøtt (University of Aarhus, Aarhus, Denmark) (10). This protein structural model contained WT sequence for the Na2 binding site (T354, S355), although we included the intracellular gate mutation (Y268A), for comparison with the experimental system (6). A fourth mutation, K288A, in TM7 was also reverted to the WT K288 in all simulations.
Simulations were carried out using NAMD, version 2.9 (63), with Charmm36 parameters (64–66), using the CMAP correction (67) and TIP3P for waters (68). The DMPC bilayer, water, and ions were represented explicitly, with 233 or 248 lipid molecules for the outward-open or inward-open proteins, respectively. The hydrated-lipid system was optimized for the LeuT structures using GRIFFIN, as described (69). The inward-open simulation system was solvated with 20,899 water molecules, 37 Na+, and 44 Cl– ions, resulting in a box size of 119 × 117 × 99 Å, which is similar to the dimension of the MSP nanodiscs (70).
During the simulations, the membrane plane was kept at a constant area, while constant temperature (310 K) was maintained through Langevin dynamics, and constant pressure (1 atm) was achieved with the Nosé–Hoover Langevin piston algorithm (63). Nonbonded interactions were switched off smoothly from 10 to 12 Å, and particle mesh Ewald summation was used to compute long-range electrostatic interactions (71, 72). The simulation time step was 2 fs. After introducing the protein into the adapted hydrated lipid patch, the entire system was energy minimized and equilibrated as described (12) using GRIFFIN (69), with a total of 1,200 steps of energy minimization followed by 8 ns of constrained MD during which constraints were progressively released.
MD trajectories (n = 3; timescale, 450–480 ns per trajectory) were examined every 100 ps (unless otherwise stated) with CHARMM c36b2 (73), VMD (74), MDanalysis (75), as well as in-house scripts based on the Radou et al. (44) approach that compute hydrogen bonds and local contacts around each amide hydrogen during the simulation so as to predict deuterium uptake for each residue (76, 77). Specifically, the fraction of deuterium D, taken up by a backbone nitrogen in a given experimental exposure time t, is predicted to depend on the protection factor of that residue, Pi, according to the following:
where kint is the intrinsic exchange rate, deduced from experimental measurements for every amino acid type, and depends on the amino acids adjacent in the sequence (78). Pi is computed for a simulation of a given length using the following:
where βC and βh have been parameterized using experimental HDX data (77). is the number of contacts of the amide nitrogen with any atom in all other residues within 6.5 Å, and is the number of hydrogen bonds it forms, according to Gromacs, version 4.6.7 (79–82). Calculation of the protection factor for the crystal structures used the same procedure.
For calculation of the rmsd and superposition of structures, transmembrane helices were defined as follows: TM1a (12–21), TM1b (25–38), TM2 (42–72), TM3 (88–124), TM4 (166–184), TM5 (192–215), TM6a (241–255), TM6b (260–268), TM7 (276–306), TM8 (337–369), TM9 (375–395), TM10 (399–427), TM11 (446–476), and TM12 (483–510). For computation of the tilt angle, we defined TM1a as the axis connecting the centers of mass of residues 11, 12, and 13, and of residues 16, 17, and 18; all six residues remained helical >70% of the simulation time. Figures of structures and simulation snapshots were made with Pymol (Schrödinger).
Acknowledgments
We thank Bruce Davis and Sitaram Meena in the S.K.S. Laboratory for valuable discussion, Gary Rudnick for helpful comments on a revised version of the manuscript, Mahmoud L. Nasr for preliminary HDX-MS experiments, Stephen Sligar for pMSP1E3D1 (Addgene plasmid no. 20066), Zhi Yue and Jana Shen for help in implementing the method of Radou et al. (44), and Birgit Schiøtt for coordinates of the inward-facing free energy minimum. This work was supported by the Alfred P. Sloan Foundation (S.K.S.); the Brain and Behavior Research Foundation (S.K.S.); a Goodman–Gilman Yale Scholar Award (to S.K.S.); NIH/National Institute of Mental Health Grants R00MH083050 (to S.K.S.) and R01MH100688 (to S.K.S.); the Division of Intramural Research of the NIH, National Institute of Neurological Disorders and Stroke (L.R.F.); and the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014).
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1613293114/-/DCSupplemental.
References
- 1.Kristensen AS, et al. SLC6 neurotransmitter transporters: Structure, function, and regulation. Pharmacol Rev. 2011;63(3):585–640. doi: 10.1124/pr.108.000869. [DOI] [PubMed] [Google Scholar]
- 2.Singh SK, Piscitelli CL, Yamashita A, Gouaux E. A competitive inhibitor traps LeuT in an open-to-out conformation. Science. 2008;322(5908):1655–1661. doi: 10.1126/science.1166777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Deckert G, et al. The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998;392(6674):353–358. doi: 10.1038/32831. [DOI] [PubMed] [Google Scholar]
- 4.Singh SK, Pal A. Biophysical approaches to the study of LeuT, a prokaryotic homolog of neurotransmitter sodium symporters. Methods Enzymol. 2015;557:167–198. doi: 10.1016/bs.mie.2015.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yamashita A, Singh SK, Kawate T, Jin Y, Gouaux E. Crystal structure of a bacterial homologue of Na+/Cl−-dependent neurotransmitter transporters. Nature. 2005;437(7056):215–223. doi: 10.1038/nature03978. [DOI] [PubMed] [Google Scholar]
- 6.Krishnamurthy H, Gouaux E. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature. 2012;481(7382):469–474. doi: 10.1038/nature10737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Malinauskaite L, et al. A conserved leucine occupies the empty substrate site of LeuT in the Na+-free return state. Nat Commun. 2016;7:11673. doi: 10.1038/ncomms11673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Forrest LR, et al. Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci USA. 2008;105(30):10338–10343. doi: 10.1073/pnas.0804659105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhao C, et al. Ion-controlled conformational dynamics in the outward-open transition from an occluded state of LeuT. Biophys J. 2012;103(5):878–888. doi: 10.1016/j.bpj.2012.07.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Grouleff J, Søndergaard S, Koldsø H, Schiøtt B. Properties of an inward-facing state of LeuT: Conformational stability and substrate release. Biophys J. 2015;108(6):1390–1399. doi: 10.1016/j.bpj.2015.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Stolzenberg S, et al. Mechanism of the association between Na+ binding and conformations at the intracellular gate in neurotransmitter:sodium symporters. J Biol Chem. 2015;290(22):13992–14003. doi: 10.1074/jbc.M114.625343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tavoulari S, et al. Two Na+ sites control conformational change in a neurotransmitter transporter homolog. J Biol Chem. 2016;291(3):1456–1471. doi: 10.1074/jbc.M115.692012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhao Y, et al. Single-molecule dynamics of gating in a neurotransmitter transporter homologue. Nature. 2010;465(7295):188–193. doi: 10.1038/nature09057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhao Y, et al. Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue. Nature. 2011;474(7349):109–113. doi: 10.1038/nature09971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kazmier K, et al. Conformational dynamics of ligand-dependent alternating access in LeuT. Nat Struct Mol Biol. 2014;21(5):472–479. doi: 10.1038/nsmb.2816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Claxton DP, et al. Ion/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter:sodium symporters. Nat Struct Mol Biol. 2010;17(7):822–829. doi: 10.1038/nsmb.1854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kniazeff J, et al. An intracellular interaction network regulates conformational transitions in the dopamine transporter. J Biol Chem. 2008;283(25):17691–17701. doi: 10.1074/jbc.M800475200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Loland CJ, Norregaard L, Litman T, Gether U. Generation of an activating Zn2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle. Proc Natl Acad Sci USA. 2002;99(3):1683–1688. doi: 10.1073/pnas.032386299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Forrest LR, Rudnick G. The rocking bundle: A mechanism for ion-coupled solute flux by symmetrical transporters. Physiology (Bethesda) 2009;24:377–386. doi: 10.1152/physiol.00030.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Garavito RM, Ferguson-Miller S. Detergents as tools in membrane biochemistry. J Biol Chem. 2001;276(35):32403–32406. doi: 10.1074/jbc.R100031200. [DOI] [PubMed] [Google Scholar]
- 21.Nasr ML, Singh SK. Radioligand binding to nanodisc-reconstituted membrane transporters assessed by the scintillation proximity assay. Biochemistry. 2014;53(1):4–6. doi: 10.1021/bi401412e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sohail A, et al. The environment shapes the inner vestibule of LeuT. PLoS Comput Biol. 2016;12(11):e1005197. doi: 10.1371/journal.pcbi.1005197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Magnani F, Tate CG, Wynne S, Williams C, Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J Biol Chem. 2004;279(37):38770–38778. doi: 10.1074/jbc.M400831200. [DOI] [PubMed] [Google Scholar]
- 24.Hong WC, Amara SG. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J Biol Chem. 2010;285(42):32616–32626. doi: 10.1074/jbc.M110.150565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Núñez E, Alonso-Torres P, Fornés A, Aragón C, López-Corcuera B. The neuronal glycine transporter GLYT2 associates with membrane rafts: Functional modulation by lipid environment. J Neurochem. 2008;105(6):2080–2090. doi: 10.1111/j.1471-4159.2008.05292.x. [DOI] [PubMed] [Google Scholar]
- 26.Divito CB, Amara SG. Close encounters of the oily kind: Regulation of transporters by lipids. Mol Interv. 2009;9(5):252–262. doi: 10.1124/mi.9.5.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Dodes Traian MM, Cattoni DI, Levi V, González Flecha FL. A two-stage model for lipid modulation of the activity of integral membrane proteins. PLoS One. 2012;7(6):e39255. doi: 10.1371/journal.pone.0039255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wang H, Elferich J, Gouaux E. Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context. Nat Struct Mol Biol. 2012;19(2):212–219. doi: 10.1038/nsmb.2215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Quick M, et al. Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation. Proc Natl Acad Sci USA. 2009;106(14):5563–5568. doi: 10.1073/pnas.0811322106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Quick M, Shi L, Zehnpfennig B, Weinstein H, Javitch JA. Experimental conditions can obscure the second high-affinity site in LeuT. Nat Struct Mol Biol. 2012;19(2):207–211. doi: 10.1038/nsmb.2197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Javitch JA. Probing structure of neurotransmitter transporters by substituted-cysteine accessibility method. Methods Enzymol. 1998;296:331–346. doi: 10.1016/s0076-6879(98)96025-6. [DOI] [PubMed] [Google Scholar]
- 32.Roy R, Hohng S, Ha T. A practical guide to single-molecule FRET. Nat Methods. 2008;5(6):507–516. doi: 10.1038/nmeth.1208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sahu ID, McCarrick RM, Lorigan GA. Use of electron paramagnetic resonance to solve biochemical problems. Biochemistry. 2013;52(35):5967–5984. doi: 10.1021/bi400834a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Jeschke G. DEER distance measurements on proteins. Annu Rev Phys Chem. 2012;63:419–446. doi: 10.1146/annurev-physchem-032511-143716. [DOI] [PubMed] [Google Scholar]
- 35.Tavoulari S, Forrest LR, Rudnick G. Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes. J Neurosci. 2009;29(30):9635–9643. doi: 10.1523/JNEUROSCI.0440-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jacobs MT, Zhang YW, Campbell SD, Rudnick G. Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter. J Biol Chem. 2007;282(40):29441–29447. doi: 10.1074/jbc.M704456200. [DOI] [PubMed] [Google Scholar]
- 37.Jaswal SS. Biological insights from hydrogen exchange mass spectrometry. Biochim Biophys Acta. 2013;1834(6):1188–1201. doi: 10.1016/j.bbapap.2012.10.011. [DOI] [PubMed] [Google Scholar]
- 38.Parker CH, et al. A conformational investigation of propeptide binding to the integral membrane protein γ-glutamyl carboxylase using nanodisc hydrogen exchange mass spectrometry. Biochemistry. 2014;53(9):1511–1520. doi: 10.1021/bi401536m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hebling CM, et al. Conformational analysis of membrane proteins in phospholipid bilayer nanodiscs by hydrogen exchange mass spectrometry. Anal Chem. 2010;82(13):5415–5419. doi: 10.1021/ac100962c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Treuheit NA, et al. Membrane interactions, ligand-dependent dynamics, and stability of cytochrome P4503A4 in lipid nanodiscs. Biochemistry. 2016;55(7):1058–1069. doi: 10.1021/acs.biochem.5b01313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Engen JR, Smithgall TE, Gmeiner WH, Smith DL. Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry. Biochemistry. 1997;36(47):14384–14391. doi: 10.1021/bi971635m. [DOI] [PubMed] [Google Scholar]
- 42.Engen JR, et al. Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry. Int Rev Phys Chem. 2013;32(1):96–127. doi: 10.1080/0144235X.2012.751175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Persson F, Halle B. How amide hydrogens exchange in native proteins. Proc Natl Acad Sci USA. 2015;112(33):10383–10388. doi: 10.1073/pnas.1506079112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Radou G, Dreyer FN, Tuma R, Paci E. Functional dynamics of hexameric helicase probed by hydrogen exchange and simulation. Biophys J. 2014;107(4):983–990. doi: 10.1016/j.bpj.2014.06.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gur M, Zomot E, Cheng MH, Bahar I. Energy landscape of LeuT from molecular simulations. J Chem Phys. 2015;143(24):243134. doi: 10.1063/1.4936133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.West GM, et al. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. Structure. 2011;19(10):1424–1432. doi: 10.1016/j.str.2011.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yang L, et al. Conformational states of the full-length glucagon receptor. Nat Commun. 2015;6:7859. doi: 10.1038/ncomms8859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Giladi M, et al. Asymmetric preorganization of inverted pair residues in the sodium-calcium exchanger. Sci Rep. 2016;6:20753. doi: 10.1038/srep20753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Cheng MH, Bahar I. Complete mapping of substrate translocation highlights the role of LeuT N-terminal segment in regulating transport cycle. PLoS Comput Biol. 2014;10(10):e1003879. doi: 10.1371/journal.pcbi.1003879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Iversen R, Mysling S, Hnida K, Jørgensen TJ, Sollid LM. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange. Proc Natl Acad Sci USA. 2014;111(48):17146–17151. doi: 10.1073/pnas.1407457111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Martens C, et al. Lipids modulate the conformational dynamics of a secondary multidrug transporter. Nat Struct Mol Biol. 2016;23(8):744–751. doi: 10.1038/nsmb.3262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Piscitelli CL, Krishnamurthy H, Gouaux E. Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site. Nature. 2010;468(7327):1129–1132. doi: 10.1038/nature09581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Christensen JJ, Hill JO, Izatt RM. Ion binding by synthetic macrocyclic compounds. Science. 1971;174(4008):459–467. doi: 10.1126/science.174.4008.459. [DOI] [PubMed] [Google Scholar]
- 54.Quick M, Javitch JA. Monitoring the function of membrane transport proteins in detergent-solubilized form. Proc Natl Acad Sci USA. 2007;104(9):3603–3608. doi: 10.1073/pnas.0609573104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Chae PS, et al. Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods. 2010;7(12):1003–1008. doi: 10.1038/nmeth.1526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Houde D, Arndt J, Domeier W, Berkowitz S, Engen JR. Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry. Anal Chem. 2009;81(14):5966. doi: 10.1021/ac9009287. [DOI] [PubMed] [Google Scholar]
- 57.Houde D, Berkowitz SA, Engen JR. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. J Pharm Sci. 2011;100(6):2071–2086. doi: 10.1002/jps.22432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Houde D, Demarest SJ. Fine details of IGF-1R activation, inhibition, and asymmetry determined by associated hydrogen /deuterium-exchange and peptide mass mapping. Structure. 2011;19(6):890–900. doi: 10.1016/j.str.2011.03.014. [DOI] [PubMed] [Google Scholar]
- 59.Houde D, Engen JR. Conformational analysis of recombinant monoclonal antibodies with hydrogen/deuterium exchange mass spectrometry. Methods Mol Biol. 2013;988:269–289. doi: 10.1007/978-1-62703-327-5_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Guttman M, Weis DD, Engen JR, Lee KK. Analysis of overlapped and noisy hydrogen/deuterium exchange mass spectra. J Am Soc Mass Spectrom. 2013;24(12):1906–1912. doi: 10.1007/s13361-013-0727-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Pantano DA, Klein ML. Characterization of membrane-protein interactions for the leucine transporter from Aquifex aeolicus by molecular dynamics calculations. J Phys Chem B. 2009;113(42):13715–13722. doi: 10.1021/jp901840u. [DOI] [PubMed] [Google Scholar]
- 62.Georgescu RE, Alexov EG, Gunner MR. Combining conformational flexibility and continuum electrostatics for calculating pKas in proteins. Biophys J. 2002;83(4):1731–1748. doi: 10.1016/S0006-3495(02)73940-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Phillips JC, et al. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26(16):1781–1802. doi: 10.1002/jcc.20289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.MacKerell AD, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B. 1998;102(18):3586–3616. doi: 10.1021/jp973084f. [DOI] [PubMed] [Google Scholar]
- 65.Klauda JB, et al. Update of the CHARMM all-atom additive force field for lipids: Validation on six lipid types. J Phys Chem B. 2010;114(23):7830–7843. doi: 10.1021/jp101759q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.MacKerell AD, Jr, Feig M, Brooks CL., 3rd Improved treatment of the protein backbone in empirical force fields. J Am Chem Soc. 2004;126(3):698–699. doi: 10.1021/ja036959e. [DOI] [PubMed] [Google Scholar]
- 67.Best RB, et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ1 and χ2 dihedral angles. J Chem Theory Comput. 2012;8(9):3257–3273. doi: 10.1021/ct300400x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926–935. [Google Scholar]
- 69.Staritzbichler R, Anselmi C, Forrest LR, Faraldo-Gómez JD. GRIFFIN: A versatile methodology for optimization of protein-lipid interfaces for membrane protein simulations. J Chem Theory Comput. 2011;7(4):1167–1176. doi: 10.1021/ct100576m. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Ritchie TK, et al. Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol. 2009;464:211–231. doi: 10.1016/S0076-6879(09)64011-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Darden T, York D, Pedersen L. Particle mesh Ewald: An N.log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092. [Google Scholar]
- 72.Essmann U, et al. A smooth particle mesh Ewald method. J Chem Phys. 1995;103:8577–8593. [Google Scholar]
- 73.Brooks BR, et al. CHARMM: The biomolecular simulation program. J Comput Chem. 2009;30(10):1545–1614. doi: 10.1002/jcc.21287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Humphrey W, Dalke A, Schulten K. VMD: Visual molecular dynamics. J Mol Graph. 1996;14(1):33–38. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
- 75.Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: A toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011;32(10):2319–2327. doi: 10.1002/jcc.21787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Vendruscolo M, Paci E, Dobson CM, Karplus M. Rare fluctuations of native proteins sampled by equilibrium hydrogen exchange. J Am Chem Soc. 2003;125(51):15686–15687. doi: 10.1021/ja036523z. [DOI] [PubMed] [Google Scholar]
- 77.Best RB, Vendruscolo M. Structural interpretation of hydrogen exchange protection factors in proteins: Characterization of the native state fluctuations of CI2. Structure. 2006;14(1):97–106. doi: 10.1016/j.str.2005.09.012. [DOI] [PubMed] [Google Scholar]
- 78.Bai Y, Milne JS, Mayne L, Englander SW. Primary structure effects on peptide group hydrogen exchange. Proteins. 1993;17(1):75–86. doi: 10.1002/prot.340170110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Lindahl E, Hess B, van der Spoel D. GROMACS 3.0: A package for molecular simulation and trajectory analysis. J Mol Model. 2001;7:306–317. [Google Scholar]
- 80.Pronk S, et al. GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7):845–854. doi: 10.1093/bioinformatics/btt055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Van Der Spoel D, et al. GROMACS: Fast, flexible, and free. J Comput Chem. 2005;26(16):1701–1718. doi: 10.1002/jcc.20291. [DOI] [PubMed] [Google Scholar]
- 82.Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008;4(3):435–447. doi: 10.1021/ct700301q. [DOI] [PubMed] [Google Scholar]
- 83.Shimamura T, et al. Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1. Science. 2010;328(5977):470–473. doi: 10.1126/science.1186303. [DOI] [PMC free article] [PubMed] [Google Scholar]














